1
Open
[.]
2
Close
[.]
3
Allotment
—
4
Listing
[.]
Issue Size
[.] shares (agg. up to ₹4,800 Cr)
Listing Date
[.]
✦ AI Insight
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|
| Assets | 1,106.80 | 797.56 |
| Total Income | 1,212.63 | 997.01 |
| Profit After Tax | 142.93 | 115.64 |
| EBITDA | 318.37 | 213.02 |
| NET Worth | 653.61 | 511.62 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Gaudium IVF & Women Health Ltd. | Mainboard | ₹165.00 Cr | ₹79 | 25.36 | ₹80.26 | +1.59% | ₹117.75 |
| Nephrocare Health Services Ltd. | Mainboard | ₹871.05 Cr | ₹460 | 63.52 | ₹471.25 | +2.45% | ₹765.35 |
| Credent Connect N Care Ltd. | SME | ₹93.90 Cr | ₹189 | 13.58 | ₹377.05 | +99.50% | ₹357.10 |
| Pramodini Medicare Ltd. | SME | ₹69.04 Cr | ₹118 | 11.34 | ₹121.65 | +3.09% | ₹118.50 |
| Modern Diagnostic & Research Centre Ltd. | SME | ₹36.89 Cr | ₹90 | 11.04 | ₹94.99 | +5.54% | ₹77.07 |
| Invicta Diagnostic Ltd. | SME | ₹28.12 Cr | ₹85 | 14.51 | ₹96.70 | +13.76% | ₹68.00 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Repayment and/or prepayment, in part or full, of certain borrowings availed by two wholly owned indirect Subsidiaries of the Company, namely, AGS Health BCP LLC and AGS Health BCP Holdings, Inc., (“Identified Subsidiaries”) through investment in such Subsidiaries | 1,600.00 |
| 2 | General corporate purposes | |
| Total | 1,600.00 |
About AGS Health IPO
Updated on Aug 12, 2026
Contact Details
AGS Health Ltd. Address‘B’ Wing, 2 nd Floor, Prince Infocity II141, Kottivakkam VillageRajiv Gandhi Salai, KandanchavadiChennai, Tamil Nadu, 60009644 45104520investors@agshealth.coVisit Website